These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38077303)

  • 1. CTSK and PLAU as Prognostic Biomarker and Related to Immune Infiltration in Pancreatic Cancer: Evidence from Bioinformatics Analysis and qPCR.
    Ding Y; Li Z; Wang H; Wang Q; Jiang H; Yu Z; Xu M
    Int J Genomics; 2023; 2023():3914687. PubMed ID: 38077303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
    Li Y; Su Z; Wei B; Qin M; Liang Z
    Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Deng M; Xiong C; He ZK; Bin Q; Song JZ; Li W; Qin J
    Front Genet; 2022; 13():825901. PubMed ID: 35295953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Candidate Therapeutic Target Genes and Profiling of Tumor-Infiltrating Immune Cells in Pancreatic Cancer via Integrated Transcriptomic Analysis.
    Ding W; Wang Y; Ma Y; Lin L; Li M
    Dis Markers; 2022; 2022():3839480. PubMed ID: 36061357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape.
    Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods.
    Lu Y; Li C; Chen H; Zhong W
    Mol Biol Rep; 2018 Dec; 45(6):1799-1807. PubMed ID: 30173393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic Cancer.
    Ding Y; Wang H; Wang Q; Jiang H; Li Z; Yu Z; Wang Q; Xu M
    J Cancer; 2024; 15(1):251-274. PubMed ID: 38164286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of key genes associated with esophageal adenocarcinoma based on bioinformatics analysis.
    Qi W; Li R; Li L; Li S; Zhang H; Tian H
    Ann Transl Med; 2021 Dec; 9(23):1711. PubMed ID: 35071405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets.
    Ma Y; Pu Y; Peng L; Luo X; Xu J; Peng Y; Tang X
    Oncol Lett; 2019 Dec; 18(6):6741-6751. PubMed ID: 31807183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
    PeerJ; 2023; 11():e16166. PubMed ID: 37790630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis.
    Wu J; Li Z; Zeng K; Wu K; Xu D; Zhou J; Xu L
    Mol Med Rep; 2019 Aug; 20(2):1343-1352. PubMed ID: 31173193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer.
    Wen L; Han Z; Du Y
    J Gastrointest Oncol; 2021 Jun; 12(3):964-980. PubMed ID: 34295549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma.
    Xu Q; Zheng J; Su Z; Chen B; Gu S
    BMC Gastroenterol; 2023 Nov; 23(1):397. PubMed ID: 37974070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
    Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
    J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.